Back to top
more

ResMed (RMD)

(Delayed Data from NYSE)

$203.15 USD

203.15
715,019

-0.73 (-0.36%)

Updated Jul 19, 2024 04:00 PM ET

After-Market: $203.00 -0.15 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for RMD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for ResMed Inc falls in the month of June.

All items in Millions except Per Share data.

6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020
Assets          
Cash & Equivalents -99,999 228 274 295 463
Receivables NA 705 576 614 475
Notes Receivable NA 0 0 0 0
Inventories NA 998 744 457 417
Other Current Assets NA 437 338 208 169
Total Current Assets NA 2,368 1,931 1,575 1,523
Net Property & Equipment NA 538 498 463 417
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 133 80 80 41
Intangibles NA 3,323 2,282 2,320 2,338
Deposits & Other Assets NA 262 172 161 149
Total Assets NA 6,752 5,096 4,728 4,587
Liabilities & Shareholders Equity 6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020
Notes Payable NA 10 10 12 12
Accounts Payable NA 151 159 138 136
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 366 345 321 270
Income Taxes Payable NA 72 45 308 65
Other Current Liabilities NA 138 109 110 99
Total Current Liabilities NA 759 689 912 603
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 210 105 103 100
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 1,431 765 643 1,164
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 105 55 70 121
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 2,622 1,735 1,842 2,090
Shareholders Equity 6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 1,772 1,682 1,622 1,571
Retained Earnings NA 4,253 3,614 3,080 2,833
Other Equity NA -273 -313 -193 -284
Treasury Stock NA 1,623 1,623 1,623 1,623
Total Shareholder's Equity NA 4,130 3,361 2,886 2,497
Total Liabilities & Shareholder's Equity NA 6,752 5,096 4,728 4,587
Total Common Equity 0 4,130 3,361 2,886 2,497
Shares Outstanding 146.90 146.90 146.20 145.50 144.60
Book Value Per Share 0.00 28.11 22.99 19.83 17.27

Fiscal Year End for ResMed Inc falls in the month of June.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 238 210 209 228
Receivables NA 779 730 692 705
Notes Receivable NA 0 0 0 0
Inventories NA 829 933 958 998
Other Current Assets NA 505 505 445 437
Total Current Assets NA 2,351 2,378 2,305 2,368
Net Property & Equipment NA 540 552 534 538
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 162 156 138 133
Intangibles NA 3,337 3,390 3,375 3,323
Deposits & Other Assets NA 277 276 265 262
Total Assets NA 6,815 6,905 6,741 6,752
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 10 10 10 10
Accounts Payable NA 177 202 177 151
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 356 332 348 366
Income Taxes Payable NA 55 47 67 72
Other Current Liabilities NA 151 149 147 138
Total Current Liabilities NA 773 764 771 759
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 219 217 209 210
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 997 1,217 1,352 1,431
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 85 46 105
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 2,185 2,423 2,490 2,622
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 1,848 1,823 1,791 1,772
Retained Earnings NA 4,770 4,540 4,402 4,253
Other Equity NA -265 -208 -320 -273
Treasury Stock NA 1,723 1,673 1,623 1,623
Total Shareholder's Equity NA 4,630 4,482 4,250 4,130
Total Liabilities & Shareholder's Equity NA 6,815 6,905 6,741 6,752
Total Common Equity 0 4,630 4,482 4,250 4,130
Shares Outstanding 146.90 146.90 147.00 147.00 146.90
Book Value Per Share 0.00 31.52 30.49 28.91 28.11